Synthesis of non-GMP small molecules

Ended Definitive Contract Awarded Last action

Contract number
HHSN261200622025C
Awardee
Awarding agency
Obligated
$1,691,200

Award facts

Opportunity
  • N02CM57030 Solicitation number
Contract value 31% obligated
  • $2,794,562.59 Current, with exercised options
  • $5,499,854.59 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 9 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Menlo Park, CA 94025, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 18 · Modified to deobligate monies that remained in the contract after contract closure. -$1
Other Administrative Action 17 · This modification deobligates $0.97 of unused arra funds. -$1
Other Administrative Action 16 · This modification provides funds for final invoice payment. $8,310
Other Administrative Action 14 · This modification deobligates the uninvoiced arra funds. -$12,964
Funding Only Action 15 · This modification provides arra funds for final invoice payment. $11,591
Other Administrative Action 13 · ; modify article f.1. And f.2. $0
Other Administrative Action 12 · ; modify article b.2., item f. $0
Exercise an Option 11 · ; modification partially exercises option 7, separately provides funding for synthesis of specific compounds. $98,265
Funding Only Action 10 · Modification provides funding to complete the synthesis project, purchase new compound, and for the administrative activities. $50,000
Exercise an Option 9 · This modification exercises option 6, and provides an increment of funding for the purchase of three compounds. $50,000
Exercise an Option 8 · Arra::yes::arra recovery- "building diverse chemical libraries for cancer drug discovery" $605,000
Other Administrative Action 7 · Arra::yes::arra recovery- cancer pathway dissection and combination therapies $304,000
Funding Only Action 6 $12,000
Funding Only Action 5 $50,000
Funding Only Action 4 $240,000
Other Administrative Action 3 $0
Funding Only Action 2 $150,000
Funding Only Action 1 $50,000
Original award $75,000
Show all 19

About this award

Written by GovTribe AI ·

This is a federal contract awarded by the National Cancer Institute, a component of the Department of Health and Human Services, to SRI International, a non-profit research and development institute. The contract is for the synthesis of non-GMP (non-Good Manufacturing Practice) small molecules, with a total ceiling value of $5,499,854.59. The contract type is Cost Plus Fixed Fee, and the ultimate completion date is June 30, 2012. SRI International has a history of supporting federal agencies such as the Department of Defense, NASA, and the Department of Education through contracts and grants, leveraging its multidisciplinary expertise in areas like biomedical sciences, computing, and aerospace. This contract does not have a small business set-aside designation.

Quick answers

Who was awarded contract HHSN261200622025C?

HHSN261200622025C was awarded to Sri International by National Cancer Institute (National Institutes of Health) on September 29, 2006.

How much is contract HHSN261200622025C worth?

The government has obligated $1,691,200 on HHSN261200622025C. Its current value, with exercised options, is $2,794,563. Its potential value, with all options, is $5,499,855.

Was contract HHSN261200622025C competed?

The extent of competition for HHSN261200622025C was full and open competition. The government received 9 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login